These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23933756)

  • 21. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
    G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.
    Marshall SM
    Diabet Med; 1999 May; 16(5):358-72. PubMed ID: 10342335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
    Kawamori R; Daida H; Tanaka Y; Miyauchi K; Kitagawa A; Hayashi D; Kishimoto J; Ikeda S; Imai Y; Yamazaki T
    BMC Cardiovasc Disord; 2006 Oct; 6():39. PubMed ID: 17029631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension.
    Tikkanen I; Chilton R; Johansen OE
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):81-6. PubMed ID: 26808705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.
    Jordan J; Yumuk V; Schlaich M; Nilsson PM; Zahorska-Markiewicz B; Grassi G; Schmieder RE; Engeli S; Finer N
    J Hypertens; 2012 Jun; 30(6):1047-55. PubMed ID: 22573071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and hypertension.
    Tuck ML; Stern N
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S8-18. PubMed ID: 1382169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 29. Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients).
    Ley L; Schumacher H
    Curr Med Res Opin; 2013 Jan; 29(1):41-53. PubMed ID: 23157465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.
    Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable].
    Pischon T; Sharma AM
    MMW Fortschr Med; 2001 Nov; 143(48):34-8. PubMed ID: 11770373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.
    Mamakou V; Eleftheriadou I; Katsiki N; Makrilakis K; Tsioufis K; Tentolouris N
    Curr Vasc Pharmacol; 2017; 16(1):70-78. PubMed ID: 29032756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
    Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The goal blood pressure in type 2 diabetes: do we have an ACCORD?
    Crouch MA
    Consult Pharm; 2010 Oct; 25(10):686, 688. PubMed ID: 21030359
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.
    Nakou E; Filippatos TD; Liberopoulos EN; Tselepis AD; Kiortsis DN; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 Jul; 9(10):1629-39. PubMed ID: 18570597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary care.
    Bramlage P; Pittrow D; Kirch W
    Curr Med Res Opin; 2004 Oct; 20(10):1625-31. PubMed ID: 15462695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats.
    Toblli JE; DeRosa G; Rivas C; Cao G; Piorno P; Pagano P; Forcada P
    J Hypertens; 2003 Mar; 21(3):611-20. PubMed ID: 12640256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.
    Paolisso G; Gambardella A; Verza M; Varricchio M
    Diabete Metab; 1990; 16(3):264-5. PubMed ID: 2210025
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
    Jansson SP; Andersson DK; Svärdsudd K
    Diabet Med; 2013 Mar; 30(3):349-57. PubMed ID: 23278364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE
    Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.